Sign In

Dr. Kenneth Kohn

Aitia app.com

Dr. Kenneth Kohn is a prominent figure with a diverse background spanning various fields such as biotechnology, chemical technology, and medical devices.

As the co-founder of OptimDosing, Dr. Kohn is known for creating cloud-based platforms that leverage AI and regression analysis to optimize drug dosages and enhance patient safety and outcomes.

His expertise includes identifying triggers for adverse events in conditions like migraines, seizures, IBS/IBD, and infectious diseases.

Dr. Kohn has a strong legal background, having served as a senior IP counsel specializing in biotechnology, medical devices, and IT.

He has extensive experience in patent preparation, prosecution, license drafting, negotiations, due diligence, and business counseling.

Throughout his career, Dr. Kohn has had the pleasure of working with prestigious clients such as Harvard, MIT, Northwestern University, Pfizer, and Dow Corning.

At Strategius Partners, he assists technology companies in fundraising, seeking investors, licensees, and potential M&A opportunities, particularly in the pharma, biotech, medical devices, and IT sectors.

As the managing partner of Prebiotic Health Sciences, Dr. Kohn leads research and development efforts focused on the anti-inflammatory, lipid metabolism-altering, and tumor growth suppression properties of probiotics.

He is also a partner at DermaDrive, a research and development firm specializing in topical delivery substrates for biologics.

Dr. Kohn holds a JD from Wayne State University Law School and dual Doctor of Philosophy (PhD) degrees in Pharmacology from Wayne State University School of Medicine.

His past roles include co-founder of OptimDosing LLC, managing partner at Prebiotic Health Sciences, owner of Kohn & Associates, and various partnerships and advisory positions in notable organizations.

Dr. Kenneth Kohn
Add to my network

Location

Farmington, Michigan, United States